
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $48.7M | $99.1M | $32.7M | $79M | $61.6M | |
Revenue Growth (YoY) | 508.64% | 103.47% | -67.07% | 142.07% | -22.03% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.9M | $6.4M | $7M | $6.2M | $8.2M | |
Other Inc / (Exp) | $10.6M | $12.4M | $10.8M | $30.3M | $63.2M | |
Operating Expenses | $6.3M | -$3.2M | -$2.9M | -$6.3M | -$3.7M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $42.5M | $102.3M | $35.5M | $85.3M | $65.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $42.5M | $102.3M | $35.5M | $85.3M | $65.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $42.5M | $102.3M | $35.5M | $85.3M | $65.3M | |
Basic EPS (Cont. Ops) | $1.28 | $3.08 | $1.07 | $2.47 | $1.78 | |
Diluted EPS (Cont. Ops) | $1.28 | $3.08 | $1.07 | $2.47 | $1.78 | |
Weighted Average Basic Share | $33.2M | $33.2M | $33.3M | $34.5M | $36.7M | |
Weighted Average Diluted Share | $33.2M | $33.2M | $33.3M | $34.5M | $36.7M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $46.9M | $115.4M | $51.4M | $109.4M | $93.6M | |
Revenue (Reported) | $48.7M | $99.1M | $32.7M | $79M | $61.6M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $46.9M | $115.4M | $51.4M | $109.4M | $93.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $22.4M | $15.9M | $3.6M | $21.8M | $16.8M | |
Revenue Growth (YoY) | -- | -28.86% | -77.45% | 507.6% | -23.21% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.5M | $1.2M | $1.3M | $1.4M | $1.8M | |
Other Inc / (Exp) | $113K | -$10M | $155K | -$14.6M | $20.9M | |
Operating Expenses | $1.9M | -$770K | -$1.1M | -$759K | -$1.1M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $20.5M | $16.7M | $4.7M | $22.6M | $17.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $20.5M | $16.7M | $4.7M | $22.6M | $17.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $20.5M | $16.7M | $4.7M | $22.6M | $17.9M | |
Basic EPS (Cont. Ops) | $0.62 | $0.50 | $0.14 | $0.62 | $0.49 | |
Diluted EPS (Cont. Ops) | $0.62 | $0.50 | $0.14 | $0.62 | $0.49 | |
Weighted Average Basic Share | $33.2M | $33.2M | $33.5M | $36.1M | $36.8M | |
Weighted Average Diluted Share | $33.2M | $33.2M | $33.5M | $36.1M | $36.8M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $21.9M | $20.5M | $8.8M | $29.1M | $26.9M | |
Revenue (Reported) | $22.4M | $15.9M | $3.6M | $21.8M | $16.8M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $21.9M | $20.5M | $8.8M | $29.1M | $26.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $48.7M | $99.1M | $32.7M | $79M | $61.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $5.9M | $6.4M | $7M | $6.2M | $8.2M | |
Other Inc / (Exp) | $10.6M | $12.4M | $10.8M | $30.3M | $63.2M | |
Operating Expenses | $6.3M | -$3.2M | -$2.9M | -$6.3M | -$3.7M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $42.5M | $102.3M | $35.5M | $85.3M | $65.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $42.5M | $102.3M | $35.5M | $85.3M | $65.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $42.5M | $102.3M | $35.5M | $85.3M | $65.3M | |
Basic EPS (Cont. Ops) | $1.28 | $3.08 | $1.06 | $2.47 | $1.78 | |
Diluted EPS (Cont. Ops) | $1.28 | $3.08 | $1.06 | $2.47 | $1.78 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $46.9M | $115.4M | $51.4M | $109.4M | $93.6M | |
Revenue (Reported) | $48.7M | $99.1M | $32.7M | $79M | $61.6M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $46.9M | $115.4M | $51.4M | $109.4M | $93.6M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $99.1M | $32.7M | $79M | $61.6M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $6.4M | $7M | $6.2M | $8.2M | -- | |
Other Inc / (Exp) | $12.4M | $10.8M | $30.3M | $63.2M | -- | |
Operating Expenses | -$3.2M | -$2.9M | -$6.3M | -$3.7M | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $102.3M | $35.5M | $85.3M | $65.3M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $102.3M | $35.5M | $85.3M | $65.3M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $102.3M | $35.5M | $85.3M | $65.3M | -- | |
Basic EPS (Cont. Ops) | $3.08 | $1.06 | $2.47 | $1.78 | -- | |
Diluted EPS (Cont. Ops) | $3.08 | $1.06 | $2.47 | $1.78 | -- | |
Weighted Average Basic Share | $132.8M | $133.2M | $137.9M | $146.9M | -- | |
Weighted Average Diluted Share | $132.8M | $133.2M | $137.9M | $146.9M | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $115.4M | $51.4M | $109.4M | $93.6M | -- | |
Revenue (Reported) | $99.1M | $32.7M | $79M | $61.6M | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $115.4M | $51.4M | $109.4M | $93.6M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.1M | $14.2M | $2.7M | $2.5M | $14.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $6.6M | $23.6M | $9.6M | $13.5M | $22.8M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $633.8M | $714.4M | $753.5M | $920.5M | $979.3M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $643.7M | $740.4M | $765.6M | $938.1M | $1B | |
Accounts Payable | $1.2M | $3M | $3.1M | $4.2M | $6.2M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $17.4M | $32.9M | $32.7M | $46.3M | $50.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $261.4M | $294.6M | $325.9M | $445.4M | $507.3M | |
Common Stock | $33K | $33K | $34K | $37K | $37K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $382.4M | $445.8M | $439.7M | $492.7M | $499.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $382.4M | $445.8M | $439.7M | $492.7M | $499.1M | |
Total Liabilities and Equity | $643.7M | $740.4M | $765.6M | $938.1M | $1B | |
Cash and Short Terms | $2.1M | $14.2M | $2.7M | $2.5M | $14.3M | |
Total Debt | $151.4M | $261.3M | $292.6M | $398.3M | $455.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.1M | $14.2M | $2.7M | $2.5M | $14.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $6.6M | $23.6M | $9.6M | $13.5M | $22.8M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $633.8M | $714.4M | $753.5M | $920.5M | $979.3M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $643.7M | $740.4M | $765.6M | $938.1M | $1B | |
Accounts Payable | $1.2M | $3M | $3.1M | $4.2M | $6.2M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $17.4M | $32.9M | $32.7M | $46.3M | $50.8M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $261.4M | $294.6M | $325.9M | $445.4M | $507.3M | |
Common Stock | $33K | $33K | $34K | $37K | $37K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -$57.5M | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $382.4M | $445.8M | $439.7M | $492.7M | $499.1M | |
Total Liabilities and Equity | $643.7M | $740.4M | $765.6M | $938.1M | $1B | |
Cash and Short Terms | $2.1M | $14.2M | $2.7M | $2.5M | $14.3M | |
Total Debt | $151.4M | $261.3M | $292.6M | $398.3M | $455.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $42.5M | $102.3M | $35.5M | $85.3M | $65.3M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$377K | -$5.4M | $2.5M | -$4.1M | $1.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$29.7M | $36.6M | -$4.5M | -$69.9M | $16.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$30.9M | -$38.9M | -$47.1M | -$76.1M | -$61M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $253.8M | $246.3M | $102.5M | $317.1M | $340.6M | |
Long-Term Debt Repaid | -$152.7M | -$134.1M | -$67.3M | -$210.5M | -$281.1M | |
Repurchase of Common Stock | -$57.5M | -$94.4M | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $28.1M | -$24.5M | -$6.7M | $69.9M | -$4.4M | |
Beginning Cash (CF) | $4.1M | $2.4M | $14.5M | $3.2M | $3.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.7M | $12.1M | -$11.2M | -$28K | $11.9M | |
Ending Cash (CF) | $2.4M | $14.5M | $3.2M | $3.2M | $15.2M | |
Levered Free Cash Flow | -$29.7M | $36.6M | -$4.5M | -$69.9M | $16.3M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $47.1M | $12M | $8.8M | -$6.5M | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $147K | $2.6M | $375K | $1.7M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $14.4M | $41.3M | -$36.4M | $12.3M | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$9M | -$11.5M | -$12.1M | -$8.8M | -- | |
Special Dividend Paid | $60K | $120K | $120K | -- | $540K | |
Long-Term Debt Issued | $29.8M | -- | $106.6M | $16.3M | -- | |
Long-Term Debt Repaid | -$10.3M | -- | -$20.8M | -$19.6M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $10.5M | -$11.5M | $71M | -$12.4M | -- | |
Beginning Cash (CF) | $2.4M | $14.5M | $3.2M | $3.2M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $24.9M | $29.8M | $34.5M | -$30K | -- | |
Ending Cash (CF) | $27.3M | $44.3M | $37.8M | $3.2M | -- | |
Levered Free Cash Flow | $14.4M | $41.3M | -$36.4M | $12.3M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $42.5M | $102.3M | $35.5M | $85.3M | $65.3M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$377K | -$5.4M | $2.5M | -$4.1M | $1.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$29.7M | $36.6M | -$4.5M | -$69.9M | $16.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$30.9M | -$38.9M | -$47.1M | -$76.1M | -$61M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $253.8M | $246.3M | $102.5M | $317.1M | $340.6M | |
Long-Term Debt Repaid | -$152.7M | -$134.1M | -$67.3M | -$210.5M | -$281.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $28.1M | -$24.5M | -$6.7M | $69.9M | -$4.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.7M | $12.1M | -$11.2M | -$28K | $11.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$29.7M | $36.6M | -$4.5M | -$69.9M | $16.3M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $47.1M | $12M | $8.8M | -$6.5M | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $147K | $2.6M | $375K | $1.7M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $14.4M | $41.3M | -$36.4M | $12.3M | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$9M | -$11.5M | -$12.1M | -$8.8M | -- | |
Special Dividend Paid | $60K | $120K | $120K | -- | $540K | |
Long-Term Debt Issued | $29.8M | -- | $106.6M | $16.3M | -- | |
Long-Term Debt Repaid | -$10.3M | -- | -$20.8M | -$19.6M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $10.5M | -$11.5M | $71M | -$12.4M | -- | |
Beginning Cash (CF) | $2.4M | $14.5M | $3.2M | $3.2M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $24.9M | $29.8M | $34.5M | -$30K | -- | |
Ending Cash (CF) | $27.3M | $44.3M | $37.8M | $3.2M | -- | |
Levered Free Cash Flow | $14.4M | $41.3M | -$36.4M | $12.3M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.